Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity

Endocrine

Volumn 25, Issue 2, 2004, Pages 97-103

  Serazin, Valérie ^a,b   Dos Santos, Esther ^a,b   Morot, Mireille ^a,b   Giudicelli, Yves ^a,b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL   (France)

Author keywords

Adipocytes; Angiotensinogen expression; Cyclic AMP

Indexed keywords

ANGIOTENSIN; CRE RECOMBINASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DNA; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR; 8 BROMO CYCLIC AMP; ACTIVATING TRANSCRIPTION FACTOR 2; ANGIOTENSINOGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ISOQUINOLINE DERIVATIVE; PROTEIN KINASE INHIBITOR; SULFONAMIDE;

ADIPOSE TISSUE; ADRENERGIC STIMULATION; ADULT; ARTICLE; BINDING AFFINITY; BODY FAT; CONTROLLED STUDY; DNA BINDING; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; STATISTICAL SIGNIFICANCE; UPREGULATION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ACTIVATING TRANSCRIPTION FACTOR 2; ADIPOSE TISSUE; ANGIOTENSINOGEN; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; PROTEIN KINASE INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES; TRANSCRIPTION FACTORS;

EID: 21244448053     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Kissebah, A. H. and Krakower, G. R. (1994). Physiol. Rev. 74, 761-811.
2. Bjorntorp, P. (1997). Lancet 350, 423-426.
3. Ailhaud, G. (2000). Int. J. Obes. Relat. Metab. Disord. 24 (Suppl 2), S1-3.
4. Saye, J. A., Ragsdale, N. V., Carey, R. M., and Peach, M. J. (1993). Am. J. Physiol. 264, C1570-1576.
5. Pinterova, L., Krizanova, O., and Zorad, S. (2000). Gen. Physiol. Biophys. 19, 329-334.
6. Engeli, S., Gorzelniak, K., Kreutz, R., Runkel, N., Distler, A., and Sharma, A. M. (1999). J. Hypertens. 17, 555-560.
7. Phillips, M. I., Speakman, E. A., and Kimura, B. (1993). Regul. Pept. 43, 1-20.
8. Reid, I. A., Morris, B. J., and Ganong, W. F. (1978). Annu. Rev. Physiol. 40, 377-410.
9. Darimont, C., Vassaux, G., Ailhaud, G., and Negrel, R. (1994). Endocrinology 135, 2030-2036.
10. Saint-Marc, P., Kozak, L. P., Ailhaud, G., Darimont, C., and Negrel, R. (2001). Endocrinology 142, 487-492.
11. Jones, B. H., Standridge, M. K., and Moustaid, N. (1997). Endocrinology 138, 1512-1519.
12. Frederich, R. C., Jr., Kahn, B. B., Peach, M. J., and Flier, J. S. (1992). Hypertension 19, 339-344.
13. Tamura, K., Umemura, S., Nyui, N., et al. (1996). Hypertension 27, 1216-1223.
14. Massiera, F., Bloch-Faure, M., Ceiler, D., et al. (2001). FASEB J. 15, 2727-2729.
15. Faloia, F., Giacchetti, G., and Mantero, F. (2000). J. Endocrinol. Invest. 23, 54-62.
16. Umemura, S., Nyui, N., Tamura, K., et al. (1997). Am. J. Hypertens. 10, 629-633.
17. Engeli, S., Negrel, R., and Sharma, A. M. (2000). Hypertension 35, 1270-1277.
18. Berglund, G. and Andersson, O. (1981). Int. J. Obes. 5(Suppl 1), 143-150.
19. Rodbell, M. (1964). J. Biol. Chem. 239, 375-380.
20. Narayanan, C. S., Cui, Y., Kumar, S., and Kumar, A. (2000). Mol. Cell. Biochem. 212, 81-90.
21. Serazin, V., Dieudonne, M. N., Morot, M., de Mazancourt, P., and Giudicelli, Y. (2004). Am. J. Physiol. Endocrinol. Metab. 286, E434-438.
22. Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C., and Sharma, A. M. (2002). Diabetes 51, 1699-1707.
23. Aubert, J., Darimont, C., Safonova, I., Ailhaud, G., and Negrel, R. (1997). Biochem. J. 328(Pt 2), 701-706.
24. Yang, S., Fang, Z., Suzuki, T., et al. (2002). J. Clin. Endocrinol. Metab. 87, 2336-2345.
25. Wang, T. T., Chen, M., Lachance, S., Delalandre, A., Carriere, S., and Chan, J. S. (1994). Kidney Int. 46, 703-710.
26. Coezy, E. D., Corvol, P., and Howlett, A. C. (1990). Cell Signal. 2, 67-76.
27. Klett, C., Nobiling, R., Gierschik, P., and Hackenthal, E. (1993). J. Biol. Chem. 268, 25095-25107.
28. Jones, B. H., Standridge, M. K., Taylor, J. W., and Moustaid, N. (1997). Am. J. Physiol. 273, R236-242.
29. Ming, M., Wang, T. T., Lachance, S., Delalandre, A., Carriere, S., and Chan, J. S. (1995). Am. J. Physiol. 268, R105-111.
30. Ohtani, R., Yayama, K., Takano, M., Itoh, N., and Okamoto, H. (1992). Endocrinology 130, 1331-1338.
31. Nielsen, D. A. and Shapiro, D. J. (1990). Mol. Endocrinol. 4, 953-957.
32. Gillis, P. and Malter, J. S. (1991). J. Biol. Chem. 266, 3172-3177.
33. Malter, J. S. and Hong, Y. (1991). J. Biol. Chem. 266, 3167-3171.
34. Fimia, G. M., De Cesare, D., and Sassone-Corsi, P. (1999). Nature 398, 165-169.
35. Anderson, E. A., Sinkey, C. A., Lawton, W. J., and Mark, A. L. (1989). Hypertension 14, 177-183.
36. Kannel, W. B., Brand, N., Skinner, J. J., Jr., Dawber, T. R., and McNamara, P. M. (1967). Ann. Intern. Med. 67, 48-59.
37. Eliahou, H. E., Iaina, A., Gaon, T., Shochat, J., and Modan, M. (1981). Int. J. Obes. 5(Suppl 1), 157-163.
38. Caulfield, M., Lavender, P., Newell-Price, J., Kamdar, S., Farrall, M., and Clark, A. J. (1996). Hypertension 28, 1123-1125.
39. Nyui, N., Tamura, K., Yamaguchi, S., et al. (1997). Hypertension 30, 859-867.
40. Cooper, R., McFarlane-Anderson, N., Bennett, F. I., et al. (1997). J. Hum. Hypertens. 11, 107-111.
41. Cooper, R., Forrester, T., Ogunbiyi, O., and Muffinda, J. (1998). J. Hypertens. 16, 571-575.
42. Van Harmelen, V., Ariapart, P., Hoffstedt, J., Lundkvist, I., Bringman, S., and Arner, P. (2000). Obes. Res. 8, 337-341.
43. Hainault, I., Nebout, G., Turban, S., Ardouin, B., Ferre, P., and Quignard-Boulange, A. (2002). Am. J. Physiol. Endocrinol. Metab. 282, E59-66.
44. Giacchetti, G., Faloia, E., Sardu, C., et al. (2000). Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2), S142-143.
45. Faloia, E., Gatti, C., Camilloni, M. A., et al. (2002). J. Endocrinol. Invest. 25, 309-314.
46. Gorzelniak, K., Engeli, S., Janke, J., Luft, F. C., and Sharma, A. M. (2002). J. Hypertens. 20, 965-973.
47. Chomczynski, P. and Sacchi, N. (1987). Anal. Biochem. 162, 156-159.
48. Serazin-Leroy, V., Morot, M., de Mazancourt, P., and Giudicelli, Y. (2000). Am. J. Physiol. Endocrinol. Metab. 279, E1398-1405.
49. Dotzlaw, H., Leygue, E., Watson, P. H., and Murphy, L. C. (1997). J. Clin. Endocrinol. Metab. 82, 2371-2374.
50. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983). Nucleic Acids Res. 11, 1475-1489.